Jerome Seidenfeld

8.2k total citations · 1 hit paper
71 papers, 5.3k citations indexed

About

Jerome Seidenfeld is a scholar working on Molecular Biology, Hematology and Biochemistry. According to data from OpenAlex, Jerome Seidenfeld has authored 71 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Hematology and 21 papers in Biochemistry. Recurrent topics in Jerome Seidenfeld's work include Polyamine Metabolism and Applications (22 papers), Amino Acid Enzymes and Metabolism (21 papers) and Erythropoietin and Anemia Treatment (18 papers). Jerome Seidenfeld is often cited by papers focused on Polyamine Metabolism and Applications (22 papers), Amino Acid Enzymes and Metabolism (21 papers) and Erythropoietin and Anemia Treatment (18 papers). Jerome Seidenfeld collaborates with scholars based in United States, Germany and United Kingdom. Jerome Seidenfeld's co-authors include Julia Bohlius, Naomi Aronson, H.G. Williams-Ashman, Charles L. Bennett, Mark R. Somerfield, Guido Schwarzer, Timothy J Wilt, J. Douglas Rizzo, Andreas Engert and Benjamin Djulbegović and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

Jerome Seidenfeld

71 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

2010 612 citations Jerome Seidenfeld, Mark R. Somerfield et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerome Seidenfeld United States	31	1.7k	1.6k	1.1k	1.1k	539	71	5.3k
Martin D. Abeloff United States	41	694 0.4×	3.1k 2.0×	988 0.9×	1.5k 1.4×	460 0.9×	119	6.4k
M. Schneider France	38	1.2k 0.7×	2.8k 1.8×	1.3k 1.2×	1.0k 0.9×	461 0.9×	108	5.8k
Susanne Osanto Netherlands	37	595 0.4×	1.4k 0.9×	766 0.7×	1.9k 1.8×	200 0.4×	95	5.1k
E Frei United States	42	1.6k 0.9×	2.2k 1.4×	1.2k 1.1×	1.8k 1.6×	635 1.2×	104	6.1k
James L. Wade United States	45	1.2k 0.7×	4.3k 2.7×	2.0k 1.8×	1.3k 1.2×	361 0.7×	153	7.6k
Robert L. Capizzi United States	37	922 0.5×	1.2k 0.8×	630 0.6×	1.3k 1.2×	369 0.7×	134	4.0k
John W. Adamson United States	37	5.5k 3.3×	775 0.5×	619 0.6×	1.3k 1.2×	2.5k 4.7×	116	8.0k
Philip S. Schein United States	48	426 0.3×	2.4k 1.5×	1.2k 1.1×	1.5k 1.4×	507 0.9×	179	6.5k
Ian Chin‐Yee Canada	27	1.6k 1.0×	559 0.4×	368 0.3×	615 0.6×	721 1.3×	127	4.0k
K. OGASAWARA Japan	39	398 0.2×	1.5k 1.0×	268 0.2×	950 0.9×	276 0.5×	195	4.9k

Countries citing papers authored by Jerome Seidenfeld

Since Specialization

Citations

This map shows the geographic impact of Jerome Seidenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Seidenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Seidenfeld more than expected).

Fields of papers citing papers by Jerome Seidenfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome Seidenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Seidenfeld. The network helps show where Jerome Seidenfeld may publish in the future.

Co-authorship network of co-authors of Jerome Seidenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome Seidenfeld. A scholar is included among the top collaborators of Jerome Seidenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome Seidenfeld. Jerome Seidenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilligan, Timothy D., Daniel F. Hayes, Jerome Seidenfeld, & Sarah Temin. (2010). ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors. Journal of Oncology Practice. 6(4). 199–202. 25 indexed citations

Seidenfeld, Jerome, et al.. (2008). HER2 testing to manage patients with breast cancer or other solid tumors.. PubMed. 1–362. 9 indexed citations

Somerfield, Mark R., et al.. (2008). American Society of Clinical Oncology Clinical Practice Guidelines: Opportunities and Challenges. Journal of Clinical Oncology. 26(24). 4022–4026. 50 indexed citations

Rizzo, J. Douglas, Mark R. Somerfield, Karen L. Hagerty, et al.. (2007). Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update. Journal of Clinical Oncology. 26(1). 132–149. 230 indexed citations

Samson, David J, Jerome Seidenfeld, George R. Simon, et al.. (2007). Evidence for Management of Small Cell Lung Cancer. CHEST Journal. 132(3). 314S–323S. 49 indexed citations

Hahn, Theresa, Donna A. Wall, Bruce M. Camitta, et al.. (2006). The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Adults: An Evidence-based Review. Biology of Blood and Marrow Transplantation. 12(1). 1–30. 77 indexed citations

Bohlius, Julia, Jayne S. Wilson, Jerome Seidenfeld, et al.. (2006). Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients. JNCI Journal of the National Cancer Institute. 98(10). 708–714. 392 indexed citations

Bohlius, Julia, Sina Langensiepen, Guido Schwarzer, et al.. (2005). Recombinant Human Erythropoietin and Overall Survival in Cancer Patients: Results of a Comprehensive Meta-analysis. JNCI Journal of the National Cancer Institute. 97(7). 489–498. 165 indexed citations

Hahn, Theresa, Donna A. Wall, Bruce M. Camitta, et al.. (2005). The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Children: An Evidence-Based Review. Biology of Blood and Marrow Transplantation. 11(11). 823–861. 48 indexed citations

10.

Piper, Molly, et al.. (2004). Islet transplantation in patients with type 1 diabetes mellitus.. PubMed. 1–6. 1 indexed citations

11.

Djulbegović, Benjamin, et al.. (2003). Nonmyeloablative Allogeneic Stem-Cell Transplantation for Hematologic Malignancies: A Systematic Review. Cancer Control. 10(1). 17–41. 23 indexed citations

12.

Samson, David J, Jerome Seidenfeld, Brian P. Schmitt, et al.. (2002). Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. 95(2). 361–376. 183 indexed citations

13.

Seidenfeld, Jerome, et al.. (2002). Radiofrequency Ablation of Unresectable Liver Metastases1. Journal of the American College of Surgeons. 195(3). 378–386. 23 indexed citations

14.

Rizzo, J. Douglas, Jerome Seidenfeld, Margaret Piper, et al.. (2001). Erythropoietin: A Paradigm for the Development of Practice Guidelines. Hematology. 2001(1). 10–30. 30 indexed citations

15.

Samma, Shoji, Kazushige Uchida, Jerome Seidenfeld, & Ryoichi Oyasu. (1990). Effects of ?-difluromethylornithine on the development of deeply invasive urinary bladder carcinomas in mice. Urological Research. 18(4). 277–280. 5 indexed citations

16.

Morimoto, Richard I., et al.. (1988). Chemical specificity for induction of stress response genes by DNA-damaging drugs in human adenocarcinoma cells. Carcinogenesis. 9(10). 1733–1738. 15 indexed citations

17.

Seidenfeld, Jerome, et al.. (1987). Effects of polyamine depletion on serum stimulation of quiescent 3T3 murine fibroblast cells. Journal of Cellular Physiology. 133(3). 546–552. 13 indexed citations

18.

Williams-Ashman, H.G., Jerome Seidenfeld, & Patrizia Galletti. (1982). Trends in the biochemical pharmacology of 5′-deoxy-5′-methylthioadenosine. Biochemical Pharmacology. 31(3). 277–288. 223 indexed citations

19.

Seidenfeld, Jerome & Laurence J. Marton. (1980). Effects of DL-alpha-methylornithine on proliferation and polyamine content of 9L rat brain tumor cells.. PubMed. 40(6). 1961–6. 22 indexed citations

20.

Seidenfeld, Jerome, J. H. P. Wilson, & H.G. Williams-Ashman. (1980). Androgenic regulation of 5′-deoxy-5′-methylthioadenosine concentrations and methylthioadenosine phosphorylase activity in relation to polyamine metabolism of rat prostate. Biochemical and Biophysical Research Communications. 95(4). 1861–1868. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact